1 Supply Summary

• 1.1 Mebendazole Introduction
• 1.2 World Mebendazole Supply & Forecast
  • 1.2.1 World Mebendazole Production Value (2021 & 2025 & 2032)
  • 1.2.2 World Mebendazole Production (2021-2032)
  • 1.2.3 World Mebendazole Pricing Trends (2021-2032)
• 1.3 World Mebendazole Production by Region (Based on Production Site)
  • 1.3.1 World Mebendazole Production Value by Region (2021-2032)
  • 1.3.2 World Mebendazole Production by Region (2021-2032)
  • 1.3.3 World Mebendazole Average Price by Region (2021-2032)
  • 1.3.4 North America Mebendazole Production (2021-2032)
  • 1.3.5 Europe Mebendazole Production (2021-2032)
  • 1.3.6 China Mebendazole Production (2021-2032)
  • 1.3.7 Japan Mebendazole Production (2021-2032)
  • 1.3.8 India Mebendazole Production (2021-2032)
  • 1.3.9 Middle East & Africa Mebendazole Production (2021-2032)
• 1.4 Market Drivers, Restraints and Trends
  • 1.4.1 Mebendazole Market Drivers
  • 1.4.2 Factors Affecting Demand
  • 1.4.3 Mebendazole Major Market Trends

2 Demand Summary

• 2.1 World Mebendazole Demand (2021-2032)
• 2.2 World Mebendazole Consumption by Region
  • 2.2.1 World Mebendazole Consumption by Region (2021-2026)
  • 2.2.2 World Mebendazole Consumption Forecast by Region (2027-2032)
• 2.3 United States Mebendazole Consumption (2021-2032)
• 2.4 China Mebendazole Consumption (2021-2032)
• 2.5 Europe Mebendazole Consumption (2021-2032)
• 2.6 Japan Mebendazole Consumption (2021-2032)
• 2.7 South Korea Mebendazole Consumption (2021-2032)
• 2.8 ASEAN Mebendazole Consumption (2021-2032)
• 2.9 India Mebendazole Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

• 3.1 World Mebendazole Production Value by Manufacturer (2021-2026)
• 3.2 World Mebendazole Production by Manufacturer (2021-2026)
• 3.3 World Mebendazole Average Price by Manufacturer (2021-2026)
• 3.4 Mebendazole Company Evaluation Quadrant
• 3.5 Industry Rank and Concentration Rate (CR)
  • 3.5.1 Global Mebendazole Industry Rank of Major Manufacturers
  • 3.5.2 Global Concentration Ratios (CR4) for Mebendazole in 2025
  • 3.5.3 Global Concentration Ratios (CR8) for Mebendazole in 2025
• 3.6 Mebendazole Market: Overall Company Footprint Analysis
  • 3.6.1 Mebendazole Market: Region Footprint
  • 3.6.2 Mebendazole Market: Company Product Type Footprint
  • 3.6.3 Mebendazole Market: Company Product Application Footprint
• 3.7 Competitive Environment
  • 3.7.1 Historical Structure of the Industry
  • 3.7.2 Barriers of Market Entry
  • 3.7.3 Factors of Competition
• 3.8 New Entrant and Capacity Expansion Plans
• 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

• 4.1 United States VS China: Mebendazole Production Value Comparison
  • 4.1.1 United States VS China: Mebendazole Production Value Comparison (2021 & 2025 & 2032)
  • 4.1.2 United States VS China: Mebendazole Production Value Market Share Comparison (2021 & 2025 & 2032)
• 4.2 United States VS China: Mebendazole Production Comparison
  • 4.2.1 United States VS China: Mebendazole Production Comparison (2021 & 2025 & 2032)
  • 4.2.2 United States VS China: Mebendazole Production Market Share Comparison (2021 & 2025 & 2032)
• 4.3 United States VS China: Mebendazole Consumption Comparison
  • 4.3.1 United States VS China: Mebendazole Consumption Comparison (2021 & 2025 & 2032)
  • 4.3.2 United States VS China: Mebendazole Consumption Market Share Comparison (2021 & 2025 & 2032)
• 4.4 United States Based Mebendazole Manufacturers and Market Share, 2021-2026
  • 4.4.1 United States Based Mebendazole Manufacturers, Headquarters and Production Site (States, Country)
  • 4.4.2 United States Based Manufacturers Mebendazole Production Value (2021-2026)
  • 4.4.3 United States Based Manufacturers Mebendazole Production (2021-2026)
• 4.5 China Based Mebendazole Manufacturers and Market Share
  • 4.5.1 China Based Mebendazole Manufacturers, Headquarters and Production Site (Province, Country)
  • 4.5.2 China Based Manufacturers Mebendazole Production Value (2021-2026)
  • 4.5.3 China Based Manufacturers Mebendazole Production (2021-2026)
• 4.6 Rest of World Based Mebendazole Manufacturers and Market Share, 2021-2026
  • 4.6.1 Rest of World Based Mebendazole Manufacturers, Headquarters and Production Site (State, Country)
  • 4.6.2 Rest of World Based Manufacturers Mebendazole Production Value (2021-2026)
  • 4.6.3 Rest of World Based Manufacturers Mebendazole Production (2021-2026)

5 Market Analysis by Type

• 5.1 World Mebendazole Market Size Overview by Type: 2021 VS 2025 VS 2032
• 5.2 Segment Introduction by Type
  • 5.2.1 Tablet
  • 5.2.2 Oral Suspension
• 5.3 Market Segment by Type
  • 5.3.1 World Mebendazole Production by Type (2021-2032)
  • 5.3.2 World Mebendazole Production Value by Type (2021-2032)
  • 5.3.3 World Mebendazole Average Price by Type (2021-2032)

6 Market Analysis by Application

• 6.1 World Mebendazole Market Size Overview by Application: 2021 VS 2025 VS 2032
• 6.2 Segment Introduction by Application
  • 6.2.1 Below 2 Years Old
  • 6.2.2 Above 2 Years Old
• 6.3 Market Segment by Application
  • 6.3.1 World Mebendazole Production by Application (2021-2032)
  • 6.3.2 World Mebendazole Production Value by Application (2021-2032)
  • 6.3.3 World Mebendazole Average Price by Application (2021-2032)

7 Company Profiles

• 7.1 Johnson & Johnson
  • 7.1.1 Johnson & Johnson Details
  • 7.1.2 Johnson & Johnson Major Business
  • 7.1.3 Johnson & Johnson Mebendazole Product and Services
  • 7.1.4 Johnson & Johnson Mebendazole Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.1.5 Johnson & Johnson Recent Developments/Updates
  • 7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
• 7.2 Amneal Pharmaceuticals
  • 7.2.1 Amneal Pharmaceuticals Details
  • 7.2.2 Amneal Pharmaceuticals Major Business
  • 7.2.3 Amneal Pharmaceuticals Mebendazole Product and Services
  • 7.2.4 Amneal Pharmaceuticals Mebendazole Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.2.5 Amneal Pharmaceuticals Recent Developments/Updates
  • 7.2.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
• 7.3 Cadila Pharmaceuticals
  • 7.3.1 Cadila Pharmaceuticals Details
  • 7.3.2 Cadila Pharmaceuticals Major Business
  • 7.3.3 Cadila Pharmaceuticals Mebendazole Product and Services
  • 7.3.4 Cadila Pharmaceuticals Mebendazole Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.3.5 Cadila Pharmaceuticals Recent Developments/Updates
  • 7.3.6 Cadila Pharmaceuticals Competitive Strengths & Weaknesses
• 7.4 Eipico
  • 7.4.1 Eipico Details
  • 7.4.2 Eipico Major Business
  • 7.4.3 Eipico Mebendazole Product and Services
  • 7.4.4 Eipico Mebendazole Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.4.5 Eipico Recent Developments/Updates
  • 7.4.6 Eipico Competitive Strengths & Weaknesses
• 7.5 Esteve Pharmaceuticals
  • 7.5.1 Esteve Pharmaceuticals Details
  • 7.5.2 Esteve Pharmaceuticals Major Business
  • 7.5.3 Esteve Pharmaceuticals Mebendazole Product and Services
  • 7.5.4 Esteve Pharmaceuticals Mebendazole Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.5.5 Esteve Pharmaceuticals Recent Developments/Updates
  • 7.5.6 Esteve Pharmaceuticals Competitive Strengths & Weaknesses
• 7.6 Tenry
  • 7.6.1 Tenry Details
  • 7.6.2 Tenry Major Business
  • 7.6.3 Tenry Mebendazole Product and Services
  • 7.6.4 Tenry Mebendazole Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.6.5 Tenry Recent Developments/Updates
  • 7.6.6 Tenry Competitive Strengths & Weaknesses

8 Industry Chain Analysis

• 8.1 Mebendazole Industry Chain
• 8.2 Mebendazole Upstream Analysis
  • 8.2.1 Mebendazole Core Raw Materials
  • 8.2.2 Main Manufacturers of Mebendazole Core Raw Materials
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis
• 8.5 Mebendazole Production Mode
• 8.6 Mebendazole Procurement Model
• 8.7 Mebendazole Industry Sales Model and Sales Channels
  • 8.7.1 Mebendazole Sales Model
  • 8.7.2 Mebendazole Typical Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Methodology
• 10.2 Research Process and Data Source

The global Mebendazole market size is expected to reach $ 205 million by 2032, rising at a market growth of 5.5% CAGR during the forecast period (2026-2032).
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for =2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
This report studies the global Mebendazole production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mebendazole and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mebendazole that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mebendazole total production and demand, 2021-2032, (K Units)
Global Mebendazole total production value, 2021-2032, (USD Million)
Global Mebendazole production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Mebendazole consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Mebendazole domestic production, consumption, key domestic manufacturers and share
Global Mebendazole production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Mebendazole production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Mebendazole production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Mebendazole market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Tenry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mebendazole market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mebendazole Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Mebendazole Market, Segmentation by Type:
Tablet
Oral Suspension
Global Mebendazole Market, Segmentation by Application:
Below 2 Years Old
Above 2 Years Old
Companies Profiled:
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Key Questions Answered:
1. How big is the global Mebendazole market?
2. What is the demand of the global Mebendazole market?
3. What is the year over year growth of the global Mebendazole market?
4. What is the production and production value of the global Mebendazole market?
5. Who are the key producers in the global Mebendazole market?
6. What are the growth factors driving the market demand?